European Journal of Epidemiology

, Volume 23, Issue 6, pp 431–434 | Cite as

Association between metabolic effects and tobacco use in 60-year-old Swedish men

  • Per Eric WändellEmail author
  • Gunilla Bolinder
  • Ulf de Faire
  • Mai-Lis Hellénius


There is a controversy whether use of smokeless tobacco is associated with an increased risk of diabetes. A population-based cross-sectional study was undertaken of 1,859 men, aged 60 years, in Stockholm County. No significant association was found between risk of diabetes and any use of tobacco, even if an association between snuff and risk of diabetes could not be excluded.


Diabetes Metabolic syndrome Smokeless tobacco Smoking Sweden 



The study was supported by grants from the Stockholm County Council, the Swedish Heart and Lung Foundation, the Swedish Council for Working Life and Social Research, the Swedish Research Council (Longitudinal Research), AstraZeneca, Pfizer, and Unilever.


  1. 1.
    Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case–control study. Lancet. 2006;368:647–58. doi: 10.1016/S0140-6736(06)69249-0.PubMedCrossRefGoogle Scholar
  2. 2.
    Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol. 2007;36:789–804. doi: 10.1093/ije/dym039.PubMedCrossRefGoogle Scholar
  3. 3.
    Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology. 2005;16:12–6. doi: 10.1097/ Scholar
  4. 4.
    Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12:387–92. doi: 10.1097/01.hjr.0000169189.22302.99.PubMedCrossRefGoogle Scholar
  5. 5.
    Haglund B, Eliasson M, Stenbeck M, Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health. 2007;35:618–22. doi: 10.1080/14034940701436949.CrossRefGoogle Scholar
  6. 6.
    Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262:351–9. doi: 10.1111/j.1365-2796.2007.01816.x.PubMedCrossRefGoogle Scholar
  7. 7.
    Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262:360–7. doi: 10.1111/j.1365-2796.2007.01813.x.PubMedCrossRefGoogle Scholar
  8. 8.
    Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men: a nested case–control study. Stroke. 2003;34:1754–9. doi: 10.1161/01.STR.0000076011.02935.A1.PubMedCrossRefGoogle Scholar
  9. 9.
    Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes. Asystematic review and meta-analysis. J Am Med Assoc. 2007;298:2654–64. doi: 10.1001/jama.298.22.2654.CrossRefGoogle Scholar
  10. 10.
    Pisinger C, Jorgensen T. Waist circumference and weight following smoking cessation in a general population: the Inter99 study. Prev Med. 2007;44:290–5. doi: 10.1016/j.ypmed.2006.11.015.PubMedCrossRefGoogle Scholar
  11. 11.
    Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590–5. doi: 10.2337/diacare.24.9.1590.PubMedCrossRefGoogle Scholar
  12. 12.
    Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med. 2004;256:101–10. doi: 10.1111/j.1365-2796.2004.01344.x.PubMedCrossRefGoogle Scholar
  13. 13.
    Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep’s clothing? Scand J Public Health. 2006;34:576–83. doi: 10.1080/14034940600665143.PubMedCrossRefGoogle Scholar
  14. 14.
    Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med. 2000;248:103–10. doi: 10.1046/j.1365-2796.2000.00708.x.PubMedCrossRefGoogle Scholar
  15. 15.
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52. doi: 10.1161/CIRCULATIONAHA.105.169404.PubMedCrossRefGoogle Scholar
  16. 16.
    Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3. doi: 10.1046/j.1464-5491.1999.00059.x.PubMedCrossRefGoogle Scholar
  17. 17.
    Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62. doi: 10.1016/S0140-6736(05) 67402-8.PubMedCrossRefGoogle Scholar
  18. 18.
    Wandell PE, de Faire U, Hellenius ML. High intake of alcohol is associated with newly diagnosed diabetes in 60 years old men and women. Nutr Metab Cardiovasc Dis. 2007;17:598–608. doi: 10.1016/j.numecd.2006.05.005.PubMedCrossRefGoogle Scholar
  19. 19.
    Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl). 1992;108:507–11. doi: 10.1007/BF02247429.CrossRefGoogle Scholar
  20. 20.
    Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995;272:151–5.PubMedGoogle Scholar
  21. 21.
    Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422–31. doi: 10.1016/S0735-1097(97) 00079-X.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Per Eric Wändell
    • 1
    Email author
  • Gunilla Bolinder
    • 2
  • Ulf de Faire
    • 3
    • 4
  • Mai-Lis Hellénius
    • 2
  1. 1.Center for Family and Community MedicineKarolinska InstitutetHuddingeSweden
  2. 2.Department of MedicineKarolinska University HospitalStockholmSweden
  3. 3.Division of Cardiovascular Epidemiology, Institute of Environmental MedicineKarolinska InstitutetStockholmSweden
  4. 4.Cardiovascular Laboratory, Department of CardiologyKarolinska University HospitalStockholmSweden

Personalised recommendations